The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo. [electronic resource]
- Biomaterials Apr 2011
- 2673-82 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't